“340B hospitals saw greater per-patient drug spend than counterparts, study finds”
Hospitals that recently enrolled in the 340B drug pricing program saw greater increases in per-patient drug spend compared to non-340B […]
340B In The News
“Court blocks Trump cuts to drug discount program”
A federal court has blocked the Trump administration’s cuts to a federal drug discount program, ruling that HHS does not
The Evidence Is Clear: Policymakers Must Get 340B Back on Track
Over the past year, there has been a growing body of evidence that the 340B program doesn’t always best serve
“A Little-Known Windfall for Some Hospitals, Now Facing Big Cuts”
A program meant to help the poor has grown beyond its original intent.
“PAUSE Act a responsible approach toward reforming the 340B drug pricing program”
With 340B being back in the news and with beneficial legislation in the works, I wanted to take the opportunity
“Our Exclusive Analysis: Nearly One in Three U.S. Pharmacies Is a 340B Contract Pharmacy; Five Chains Dominate”
Pharmacies continue to profit from the 340B Drug Pricing Program’s explosive growth.
“Commentary: Drug discount program aiding profits not patients”
Reforms are needed to a 1992 law intended to keep medication costs low for low-income patients.
“New study finds some US hospitals mark up medicine prices at least 700”
A new analysis from The Moran Company found nearly one in five hospitals in the USA marks up medicine prices
“Letter: Discount drug program”
Established in 1992, the 340B drug discount program was intended to help health care providers who mainly care for underserved,